Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Exchange Rate Effect (2020 - 2025)

Barinthus Biotherapeutics' Exchange Rate Effect history spans 6 years, with the latest figure at $418000.0 for Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 105.69% year-over-year to $418000.0; the TTM value through Dec 2025 reached $7.0 million, up 447.01%, while the annual FY2025 figure was $7.0 million, 447.01% up from the prior year.
  • Exchange Rate Effect reached $418000.0 in Q4 2025 per BRNS's latest filing, up from -$1.8 million in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $6.2 million in Q3 2024 to a low of -$7.3 million in Q4 2024.
  • Average Exchange Rate Effect over 5 years is $44550.0, with a median of $270500.0 recorded in 2021.
  • Peak YoY movement for Exchange Rate Effect: plummeted 2235.74% in 2021, then skyrocketed 1604.17% in 2022.
  • A 5-year view of Exchange Rate Effect shows it stood at $336000.0 in 2021, then surged by 1604.17% to $5.7 million in 2022, then tumbled by 80.41% to $1.1 million in 2023, then crashed by 754.81% to -$7.3 million in 2024, then surged by 105.69% to $418000.0 in 2025.
  • Per Business Quant, the three most recent readings for BRNS's Exchange Rate Effect are $418000.0 (Q4 2025), -$1.8 million (Q3 2025), and $5.3 million (Q2 2025).